Patents by Inventor Haiyong Peng

Haiyong Peng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ROR2 antibody compositions and related methods
    Patent number: 11834501
    Abstract: The invention provides antibodies, antibody fragments or antigen-binding fragments, as well as related antibody drug conjugates (ADCs) and chimeric antigen receptors (CARs), that specifically recognize human ROR2. Also provided in the invention are methods of using such antibodies in various diagnostic and therapeutic applications.
    Type: Grant
    Filed: July 22, 2021
    Date of Patent: December 5, 2023
    Assignee: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
    Inventors: Christoph Rader, Haiyong Peng, Xiuling Li
  • ANTIBODIES TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3d AND USE THEREOF
    Publication number: 20230029635
    Abstract: Disclosed are anti-C3d antibodies or fragments thereof. Also disclosed are methods of killing cancer cells, methods of preparing anti-C3d antibodies, and pharmaceutical compositions.
    Type: Application
    Filed: December 8, 2020
    Publication date: February 2, 2023
    Applicants: The United States of America,as represented by the Secretary,Department of Health and Human Services, The Scripps Research Institute
    Inventors: Adrian Wiestner, Christoph Rader, Haiyong Peng, Sivasubramanian Baskar, Erika Gaglione
  • ROR1 ANTIBODY COMPOSITIONS AND RELATED METHODS
    Publication number: 20220153839
    Abstract: The invention provides antibodies, antibody drug conjugates, antibody-based fragments or antibody fragments (antigen-binding fragments), as well as antibody drug conjugates (ADCs) and chimeric antigen receptors (CARs), that specifically recognize human ROR1 and related compositions. Also provided in the invention are methods of using such antibodies in various diagnostic and therapeutic applications.
    Type: Application
    Filed: December 28, 2021
    Publication date: May 19, 2022
    Inventors: Christoph RADER, Haiyong PENG, Roger BEERLI, Lorenz WALDMEIER, Ulf GRAWUNDER
  • ROR1 antibody compositions and related methods
    Patent number: 11242388
    Abstract: The invention provides antibodies, antibody drug conjugates, antibody-based fragments or antibody fragments (antigen-binding fragments), as well as antibody drug conjugates (ADCs) and chimeric antigen receptors (CARs), that specifically recognize human ROR1 and related compositions. Also provided in the invention are methods of using such antibodies in various diagnostic and therapeutic applications.
    Type: Grant
    Filed: February 28, 2020
    Date of Patent: February 8, 2022
    Assignees: NBE-Therapeutics AG, The Scripps Research Institute
    Inventors: Christoph Rader, Haiyong Peng, Roger Beerli, Lorenz Waldmeier, Ulf Grawunder
  • ROR2 ANTIBODY COMPOSITIONS AND RELATED METHODS
    Publication number: 20210347892
    Abstract: The invention provides antibodies, antibody fragments or antigen-binding fragments, as well as related antibody drug conjugates (ADCs) and chimeric antigen receptors (CARs), that specifically recognize human ROR2. Also provided in the invention are methods of using such antibodies in various diagnostic and therapeutic applications.
    Type: Application
    Filed: July 22, 2021
    Publication date: November 11, 2021
    Inventors: Christoph Rader, Haiyong Peng, Xiuling Li
  • ROR2 antibody compositions and related methods
    Patent number: 11078273
    Abstract: The disclosure provides antibodies, antibody fragments or antigen-binding fragments, as well as related antibody drug conjugates (ADCs) and chimeric antigen receptors (CARs), that specifically recognize human ROR2, Also provided in the disclosure are methods of using such antibodies in various diagnostic and therapeutic applications.
    Type: Grant
    Filed: January 20, 2017
    Date of Patent: August 3, 2021
    Assignee: The Scripps Research Institute
    Inventors: Christoph Rader, Haiyong Peng, Xiuling Li
  • ROR1 Antibody Compositions and Related Methods
    Publication number: 20200299381
    Abstract: The invention provides antibodies, antibody drug conjugates, antibody-based fragments or antibody fragments (antigen-binding fragments), as well as antibody drug conjugates (ADCs) and chimeric antigen receptors (CARs), that specifically recognize human ROR1 and related compositions. Also provided in the invention are methods of using such antibodies in various diagnostic and therapeutic applications.
    Type: Application
    Filed: February 28, 2020
    Publication date: September 24, 2020
    Inventors: Christoph Rader, Haiyong Peng, Roger Beerli, Lorenz Waldmeier, Ulf Grawunder
  • ROR1 antibody compositions and related methods
    Patent number: 10618959
    Abstract: The invention provides antibodies, antibody drug conjugates, antibody-based fragments or antibody fragments (antigen-binding fragments), as well as antibody drug conjugates (ADCs) and chimeric antigen receptors (CARs), that specifically recognize human ROR1 and related compositions. Also provided in the invention are methods of using such antibodies in various diagnostic and therapeutic applications.
    Type: Grant
    Filed: July 19, 2018
    Date of Patent: April 14, 2020
    Assignees: NBE-Therapeutics AG, The Scripps Research Institute
    Inventors: Christoph Rader, Haiyong Peng, Roger Beerli, Lorenz Waldmeier, Ulf Grawunder
  • ROR2 ANTIBODY COMPOSITIONS AND RELATED METHODS
    Publication number: 20190031754
    Abstract: The disclosure provides antibodies, antibody fragments or antigen-binding fragments, as well as related antibody drug conjugates (ADCs) and chimeric antigen receptors (CARs), that specifically recognize human ROR2, Also provided in the disclosure are methods of using such antibodies in various diagnostic and therapeutic applications,
    Type: Application
    Filed: January 20, 2017
    Publication date: January 31, 2019
    Inventors: Christoph Rader, Haiyong Peng, Xiuling Li
  • ROR1 Antibody Compositions and Related Methods
    Publication number: 20180340026
    Abstract: The invention provides antibodies, antibody drug conjugates, antibody-based fragments or antibody fragments (antigen-binding fragments), as well as antibody drug conjugates (ADCs) and chimeric antigen receptors (CARs), that specifically recognize human ROR1 and related compositions. Also provided in the invention are methods of using such antibodies in various diagnostic and therapeutic applications.
    Type: Application
    Filed: July 19, 2018
    Publication date: November 29, 2018
    Inventors: Christoph Rader, Haiyong Peng, Roger Beerli, Lorenz Waldmeier, Ulf Grawunder